Quick Answer
Cytosorbents Corp reported Net Income of -$8.20 million for fiscal year 2025.
Cytosorbents Corp Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$8.20M | +60.4% |
| 2024 | -$20.72M | +29.2% |
| 2023 | -$29.25M | +10.9% |
| 2022 | -$32.81M | -33.6% |
| 2021 | -$24.56M | -213.4% |
| 2020 | -$7.84M | +59.3% |
| 2019 | -$19.27M | -11.9% |
| 2018 | -$17.21M | -103.4% |
| 2017 | -$8.46M | +28.1% |
| 2016 | -$11.76M | -24.1% |
| 2015 | -$9.48M | -1.7% |
| 2014 | -$9.32M | -99.3% |
| 2013 | -$4.68M | -27.7% |
| 2012 | -$3.66M | +33.2% |
| 2011 | -$5.48M | -88.4% |
| 2010 | -$2.91M | -6.3% |
| 2009 | -$2.74M | +9.3% |
| 2008 | -$3.02M | +9.9% |
| 2007 | -$3.35M | +95.6% |
| 2006 | -$76.72M | -1992.9% |
| 2005 | -$3.67M | -234.2% |
| 2004 | -$1.10M | +81.8% |
| 2003 | -$6.01M | +49.4% |
| 2002 | -$11.87M | +22.9% |
| 2001 | -$15.39M | -402.0% |
| 2000 | -$3.07M | +71.5% |
| 1999 | -$10.75M | -475.9% |
| 1998 | -$1.87M | +64.5% |
| 1997 | -$5.26M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$3.17M | -14.5% | -262.8% |
| June 30, 2025 | $1.95M | +145.3% | +231.7% |
| March 31, 2025 | -$1.48M | +75.7% | +46.6% |
| September 30, 2024 | -$2.77M | +69.9% | +35.5% |
| June 30, 2024 | -$4.29M | +30.2% | +29.5% |
| March 31, 2024 | -$6.09M | +16.9% | +33.8% |
| September 30, 2023 | -$9.19M | +24.6% | -49.4% |
| June 30, 2023 | -$6.15M | +43.4% | +16.0% |
- Cytosorbents Corp showed an increase of +60.4% in Net Income compared to the prior fiscal year.
- Over the 1997–2025 period, Cytosorbents Corp’s net income has declined by 56.0% (from -$5.26 million to -$8.20 million).
- The most recent figure is from Cytosorbents Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: